Marin Jukic

Publikationer
Populärvetenskap och samverkan

Artiklar

Article: NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2023;49(1):e12867
The humanised CYP2C19 transgenic mouse exhibits cerebellar atrophy and movement impairment reminiscent of ataxia
Milosavljevic F; Brusini I; Atanasov A; Manojlovic M; Vucic M; Orescanin-Dusic Z; Brkljacic J; Miljevic C; Nikolic-Kokic A; Blagojevic D; Wang C; Damberg P; Pesic V; Tyndale RF; Ingelman-Sundberg M; Jukic MM
Article: CLINICAL AND TRANSLATIONAL SCIENCE. 2023;16(1):62-72
Impact of NFIB and CYP1A variants on clozapine serum concentration-A retrospective naturalistic cohort study on 526 patients with known smoking habits
Lenk HC; Lovsletten Smith R; O'Connell KS; Jukic MM; Kringen MK; Andreassen OA; Ingelman-Sundberg M; Molden E
Article: CLINICAL AND TRANSLATIONAL SCIENCE. 2022;15(9):2135-2145
Impact of the novel CYP2C:TG haplotype and CYP2B6 variants on sertraline exposure in a large patient population
Braten LS; Ingelman-Sundberg M; Jukic MM; Molden E; Kringen MK
Article: JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY. 2022;42(4):396-399
Association Between CYP2D6 Metabolizer Status and Vortioxetine Exposure and Treatment Switching A Retrospective, Naturalistic Cohort Study Using Therapeutic Drug Monitoring Data From 640 Patients
Frederiksen T; Smith RL; Jukic MM; Molden E
Article: PSYCHIATRY RESEARCH. 2022;312:114535
CYP2C19 slow metabolizer phenotype is associated with lower antidepressant efficacy and tolerability
Jokovic D; Milosavljevic F; Stojanovic Z; Supic G; Vojvodic D; Uzelac B; Jukic MM; Curcin AP
Article: CELLS. 2022;11(10):1597
Hepatocyte Thorns, A Novel Drug-Induced Stress Response in Human and Mouse Liver Spheroids
Pridgeon CS; Bolhuis DP; Milosavljevic F; Manojlovic M; Vegvari A; Gaetani M; Jukic MM; Ingelman-Sundberg M
Article: CLINICAL PHARMACOLOGY AND THERAPEUTICS. 2022;111(5):1165-1174
The Polymorphic Nuclear Factor NFIB Regulates Hepatic CYP2D6 Expression and Influences Risperidone Metabolism in Psychiatric Patients
Lenk HC; Kloditz K; Johansson I; Smith RL; Jukic M; Molden E; Ingelman-Sundberg M
Article: CLINICAL PHARMACOLOGY AND THERAPEUTICS. 2021;110(3):750-758
Evaluation of the CYP2D6 Haplotype Activity Scores Based on Metabolic Ratios of 4,700 Patients Treated With Three Different CYP2D6 Substrates
Jukic MM; Smith RL; Molden E; Ingelman-Sundberg M
Article: CLINICAL PHARMACOLOGY AND THERAPEUTICS. 2021;110(3):786-793
A Novel CYP2C-Haplotype Associated With Ultrarapid Metabolism of Escitalopram
Braten LS; Haslemo T; Jukic MM; Ivanov M; Ingelman-Sundberg M; Molden E; Kringen MK
Article: PSYCHONEUROENDOCRINOLOGY. 2021;129:105234
Synergy of oxytocin and citalopram in modulating Itgb3/Chl1 interplay: Relevance to sensitivity to SSRI therapy
Stanic D; Oved K; Israel-Elgali I; Jukic M; Batinic B; Puskas N; Shomron N; Gurwitz D; Pesic V
Article: SCHIZOPHRENIA RESEARCH. 2021;228:590-596
Rates of complete nonadherence among atypical antipsychotic drugs: A study using blood samples from 13,217 outpatients with psychotic disorders
Smith RL; Tveito M; Kylleso L; Jukic MM; Ingelman-Sundberg M; Andreassen OA; Molden E
Article: FRONTIERS IN PHARMACOLOGY. 2021;12:650750
CYP2D6 Reduced Function Variants and Genotype/Phenotype Translations of CYP2D6 Intermediate Metabolizers: Implications for Personalized Drug Dosing in Psychiatry
Molden E; Jukic MM
Article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2020;37:64-69
Impact of antipsychotic polypharmacy on nonadherence of oral antipsychotic drugs - A study based on blood sample analyses from 24,239 patients
Smith RL; Tveito M; Kylleso L; Jukic MM; Ingelman-Sundberg M; Andreassen OA; Molden E
Article: NEUROPSYCHOPHARMACOLOGY. 2020;45(3):570-576
Impact of CYP2C19 genotype on sertraline exposure in 1200 Scandinavian patients
Braten LS; Haslemo T; Jukic MM; Ingelman-Sundberg M; Molden E; Kringen MK
Article: FRONTIERS IN NEUROANATOMY. 2020;14:578900
Long-Term Effects of Maternal Deprivation on the Volume of Dopaminergic Nuclei and Number of Dopaminergic Neurons in Substantia Nigra and Ventral Tegmental Area in Rats
Kapor S; Aksic M; Puskas L; Jukic M; Poleksic J; Milosavljevic F; Bjelica S; Filipovic B
Article: THE LANCET PSYCHIATRY. 2019;6(5):418-426
Effect of CYP2D6 genotype on exposure and efficacy of risperidone and aripiprazole: a retrospective, cohort study
Jukic MM; Smith RL; Haslemo T; Molden E; Ingelman-Sundberg M
Article: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2019;85(1):194-201
Significantly lower CYP2D6 metabolism measured as the O/N-desmethylvenlafaxine metabolic ratio in carriers of CYP2D6*41 versus CYP2D6*9 or CYP2D6*10: a study on therapeutic drug monitoring data from 1003 genotyped Scandinavian patients
Haslemo T; Eliasson E; Jukic MM; Ingelman-Sundberg M; Molden E
Article: PSYCHIATRY RESEARCH. 2018;269:746-752
Association between neurological soft signs and antioxidant enzyme activity in schizophrenic patients
Miljevic CD; Nikolic-Kokic A; Blagojevic D; Milovanovic M; Munjiza A; Jukic MM; Pesic V; Lecic-Tosevski D; Spasic MB
Article: PHARMACOGENOMICS. 2018;19(12):931-936
Functional characterization of CYP2D7 gene variants
Jukic MM; Lauschke VM; Saito T; Hiratsuka M; Ingelman-Sundberg M
Article: AMERICAN JOURNAL OF PSYCHIATRY. 2018;175(5):463-470
Impact of CYP2C19 Genotype on Escitalopram Exposure and Therapeutic Failure: A Retrospective Study Based on 2,087 Patients
Jukic MM; Haslemo T; Molden E; Ingelman-Sundberg M
Article: JOURNAL OF NEUROSCIENCE. 2018;38(7):1662-1676
BMP/SMAD Pathway Promotes Neurogenesis of Midbrain Dopaminergic Neurons In Vivo and in Human Induced Pluripotent and Neural Stem Cells.
Jovanovic VM; Salti A; Tilleman H; Zega K; Jukic MM; Zou H; Friedel RH; Prakash N; Blaess S; Edenhofer F; Brodski C
Article: MOLECULAR PSYCHIATRY. 2017;22(8):1155-1163
Elevated CYP2C19 expression is associated with depressive symptoms and hippocampal homeostasis impairment
Jukic MM; Opel N; Stroem J; Carrillo-Roa T; Miksys S; Novalen M; Renblom A; Sim SC; Penas-Lledo EM; Courtet P; Llerena A; Baune BT; de Quervain DJ; Papassotiropoulos A; Tyndale RF; Binder EB; Dannlowski U; Ingelman-Sundberg M
Article: FRONTIERS IN MOLECULAR NEUROSCIENCE. 2017;10:372
Dusp16 Deficiency Causes Congenital Obstructive Hydrocephalus and Brain Overgrowth by Expansion of the Neural Progenitor Pool
Zega K; Jovanovic VM; Vitic Z; Niedzielska M; Knaapi L; Jukic MM; Partanen J; Friedel RF; Lang R; Brodski C
Article: DRUG DEVELOPMENT RESEARCH. 2016;77(7):414-422
Molecular Mechanism and Clinical Relevance of Ketamine as Rapid-Acting Antidepressant
Pesic V; Petrovic J; Jukic MM
Article: NEUROSCIENCE. 2015;290:147-158
Deciphering the spatio-temporal expression and stress regulation of Fam107B, the paralog of the resilience-promoting protein DRR1 in the mouse brain.
Masana M; Jukic MM; Kretzschmar A; Wagner KV; Westerholz S; Schmidt MV; Rein T; Brodski C; Müller MB
Article: NEUROPSYCHOPHARMACOLOGY. 2015;40(4):839-848
Abnormal development of monoaminergic neurons is implicated in mood fluctuations and bipolar disorder.
Jukic MM; Carrillo-Roa T; Bar M; Becker G; Jovanovic VM; Zega K; Binder EB; Brodski C
Article: PLOS ONE. 2015;10(10):e0139697
Otx2 Requires Lmx1b to Control the Development of Mesodiencephalic Dopaminergic Neurons.
Sherf O; Nashelsky Zolotov L; Liser K; Tilleman H; Jovanovic VM; Zega K; Jukic MM; Brodski C
Visa fler

Alla övriga publikationer

Review: TRENDS IN PHARMACOLOGICAL SCIENCES. 2022;43(12):1055-1069
Pharmacogenomics in treatment of depression and psychosis: an update
Jukic M; Milosavljevi F; Molden E; Ingelman-Sundberg M
Review: JAMA PSYCHIATRY. 2021;78(3):270-280
Association of CYP2C19 and CYP2D6 Poor and Intermediate Metabolizer Status With Antidepressant and Antipsychotic Exposure A Systematic Review and Meta-analysis
Milosavljevic F; Bukvic N; Pavlovic Z; Miljevic C; Pesic V; Molden E; Ingelman-Sundberg M; Leucht S; Jukic MM
Editorial comment: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2020;37:100-101
Can G_i1 biased 5-HT_2A inverse agonists improve the treatment of psychosis?
Jukic MM
Review: FRONTIERS IN PSYCHIATRY. 2020;11:94
Pharmacogenomics of Antidepressant and Antipsychotic Treatment: How Far Have We Got and Where Are We Going?
van Westrenhen R; Aitchison KJ; Ingelman-Sundberg M; Jukic MM
Corrigendum: FRONTIERS IN MOLECULAR NEUROSCIENCE. 2018;11:29
Dusp 16 Deficiency Causes Congenital Obstructive Hydrocephalus and Brain Overgrowth by Expansion of the Neural Progenitor Pool (vol 10, 372, 2017)
Zega K; Jovanovic VM; Vitic Z; Niedzielska M; Knaapi L; Jukic MM; Partanen J; Friedel RH; Lang R; Brodski C
Editorial comment: PHARMACOGENOMICS. 2014;15(15):1841-1844
Polymorphic expression of CYP2C19 and CYP2D6 in the developing and adult human brain causing variability in cognition, risk for depression and suicide: the search for the endogenous substrates
Ingelman-Sundberg M; Persson A; Jukic MM

Artiklar

Alla övriga publikationer

Nyheter från KI

Kalenderhändelser från KI